Benefits of dual bronchodilation with QVA149 once daily versus placebo, indacaterol, NVA237 and tiotropium in patients with COPD: The SHINE study

被引：0
|
作者：
Bateman, Eric [1 ]
Ferguson, Gary T. [2 ]
Barnes, Neil [3 ]
Gallagher, Nicola [4 ]
Green, Yulia [4 ]
Horton, Rachael [4 ]
Henley, Michelle [4 ]
Banerji, Donald [5 ]
机构：
[1] Univ Cape Town, Dept Med, Rondebosch, South Africa
[2] Pulm Res Inst Southeast Michigan, Pulm Dept, Livonia, MI USA
[3] Barts Hlth NHS Trust, London Chest Hosp, London, England
[4] Novartis Horsham Res Ctr, Resp Dept, Horsham, W Sussex, England
[5] Novartis Pharmaceut, Resp Dept, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
COPD; -; management; Bronchodilators;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
7248
引用
收藏
页数：2
相关论文
共 50 条
  • [41] QVA149 ONCE DAILY IMPROVES EXERCISE TOLERANCE AND LUNG FUNCTION IN PATIENTS WITH MODERATE TO SEVERE COPD: THE BRIGHT STUDY
    Beeh, K. M.
    Korn, S.
    Beier, J.
    Jadayel, D.
    Henley, M.
    Tylek, J.
    Berhane, I.
    D'Andrea, P.
    Banerji, D. Donald
    THORAX, 2012, 67 : A147 - A147
  • [42] Safety And Tolerability Of Qva149, Glycopyrronium And Tiotropium In Patients With Severe To Very Severe COPD: The Spark Study
    Decramer, M.
    Wedzicha, J. A.
    Sandstrom, T.
    Niewoehner, D.
    Taylor, A. Fowler
    D'Andrea, P.
    Arrasate, C.
    Berhane, I.
    Chen, H.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [43] Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients
    Vogelmeier, C.
    Verkindre, C.
    Cheung, D.
    Galdiz, J. B.
    Guclu, S. Z.
    Spangenthal, S.
    Overend, T.
    Henley, M.
    Mizutani, G.
    Zeldin, R. K.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (05) : 438 - 444
  • [44] DUAL BRONCHODILATION WITH ONCE-DAILY QVA149 IMPROVES LUNG FUNCTION, DYSPNOEA AND HEALTH STATUS AND REDUCES SYMPTOMS, RESCUE MEDICATION USE AND EXACERBATIONS IN PATIENTS WITH COPD: THE IGNITE TRIALS
    Thompson, P.
    Wark, P.
    Lindstrom, S.
    Frith, P.
    RESPIROLOGY, 2014, 19 : 35 - 35
  • [45] In Patients With More Severe Dyspnea, Dual Bronchodilation With Once-Daily Qva149 Improves Dyspnea, Health Status, And Lung Function Compared With Tiotropium And Salmeterol/fluticasone Combination: The Ignite Trials
    Mahler, D. A.
    D'Urzo, A. D.
    Keininger, D. L.
    Mezzi, K.
    Banerji, D. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [46] ONCE DAILY QVA149 PROVIDES SUPERIOR IMPROVEMENTS IN LUNG FUNCTION COMPARED WITH GLYCOPYRRONIUM AND TIOTROPIUM IN SEVERE COPD PATIENTS: A 52 WEEK POOLED ANALYSIS
    Frenzel, C.
    Banerji, D.
    Fowlertaylor, A.
    Kho, P.
    Chen, H.
    Alagappan, V
    RESPIROLOGY, 2014, 19 : 118 - 118
  • [47] Once-Daily Qva149 Provides Consistently Superior Peak Fev1 In COPD Patients
    Barnes, N.
    Hashimoto, S.
    Nagase, T.
    Chen, H.
    Gallagher, N.
    D'Andrea, P.
    Alagappan, V.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [48] Once-daily QVA149 demonstrates superior improvements in patient-reported dyspnea compared to tiotropium in patients with moderate-to-severe COPD: The BLAZE study
    Mahler, Donald A.
    Decramer, Marc
    D'Urzo, Anthony
    Worth, Heinrich
    White, Tracy
    Alagappan, Vijay
    Chen, Hungta
    Kulich, Karoly
    Gallagher, Nicola
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [49] Once-daily QVA149 reduces exacerbations and improves health status in comparison with glycopyrronium and tiotropium in patients with severe-to-very severe COPD: The SPARK study
    Decramer, Marc
    Wedzicha, Jadwiga A.
    Ficker, Joachim H.
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [50] Once-Daily QVA149 Reduces Exacerbations and Improves Health Status in Comparison With Glycopyrronium and Tiotropium in Patients With Severe-to-Very Severe COPD: The SPARK Study
    Wedzicha, Jadwiga
    Ficker, Joachim
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    CHEST, 2014, 145 (03)
12345